Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001415639 | SCV001617800 | likely benign | Pyridoxine-dependent epilepsy | 2021-01-11 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002390747 | SCV002696985 | likely benign | Inborn genetic diseases | 2017-06-07 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Genome- |
RCV001415639 | SCV004050106 | likely benign | Pyridoxine-dependent epilepsy | 2023-04-11 | criteria provided, single submitter | clinical testing |